Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Lung Neoplasms × apatinib × Clear all

Phase

Status

Unknown 9 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Advanced Non-squamous Non-small-cell Lung Cancer 2 Stomach Neoplasms 1 Sarcoma 1 Lung Neoplasms 1 Esthesioneuroblastoma, Olfactory 1 Esophageal Neoplasms 1

Interventions

Carboplatin 18 Radiotherapy 10 Cisplatin 10 Pemetrexed 8 Paclitaxel 8 durvalumab 6 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 Radiosurgery 5 Etoposide 5 Surveys and Questionnaires 4 Radiation 4 Nivolumab 4 Erlotinib Hydrochloride 4 Docetaxel 4 pembrolizumab 3 atezolizumab 3 Taxes 3 Standard of Care 3 Specimen Handling 3 Platinum 3 Cetuximab 3 Bronchoscopy 3 Biopsy 3 Bevacizumab 3 1,2-diaminocyclohexaneplatinum II citrate 3 sapanisertib 2 etoposide phosphate 2 capmatinib 2 Vinorelbine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03164694 2024-12-10

APPEAL

Sun Yat-sen University

Phase 2 Withdrawn

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡